Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...
Zacks.com on MSN3d
FDA Approves Novartis Drug for Rare Kidney Disease TreatmentNovartis wins FDA approval for the label expansion of Fabhalta for a third indication - treatment of adults with C3 ...
The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...
The Punch on MSN2d
Youths access dangerous drugs unhindered as regulators appear helplessNigeria’s streets have become a free-for-all market for hard drugs, including opioids and other harmful substances. SODIQ ...
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage ...
In general, VRBPAC almost always recommends the same influenza strains as the World Health Organization (WHO) for egg-based ...
Following a recommendation by the commission to set up the board, the government of Karnataka constituted a technical committee in ... and a National Medicinal Plants Board.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback